| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.92M | - | |
| CEO | 143.1K | $1.50M | - | |
| Other | 52.0K | $547.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2015 | Haqq Christopher | Chief Medical Officer | Sell | 2,500 | $62.94 | $157,353.00 | -0.5% | |
| Jul 1, 2015 | Haqq Christopher | Chief Medical Officer | Sell | 2,500 | $51.68 | $129,196.00 | -0.5% | |
| Jul 1, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 3,900 | $49.40 | $192,669.00 | -0.1% | |
| Jun 18, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 5,200 | $54.72 | $284,545.00 | -0.2% | |
| Jun 15, 2015 | McGrath John | Chief Financial Officer | Sell | 10,000 | $50.00 | $500,000.00 | -26.8% | |
| Jun 15, 2015 | Haqq Christopher | Chief Medical Officer | Sell | 7,500 | $46.42 | $348,116.00 | -1.0% | |
| Jun 5, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 6,400 | $42.91 | $274,596.00 | -0.3% | |
| Jun 1, 2015 | Haqq Christopher | Chief Medical Officer | Sell | 2,500 | $41.47 | $103,664.50 | -0.3% | |
| May 29, 2015 | McGrath John | Chief Financial Officer | Sell | 10,000 | $40.00 | $400,000.00 | -21.1% | |
| May 22, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,000 | $37.56 | $150,222.00 | -0.2% |